Efficacy of idebenone on respiratory function in patients with Duchenne muscular dystrophy not using glucocorticoids (DELOS): a double-blind randomised placebo-controlled phase 3 trial (Q34669498)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Efficacy of idebenone on respiratory function in patients with Duchenne muscular dystrophy not using glucocorticoids (DELOS): a double-blind randomised placebo-controlled phase 3 trial	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Efficacy of idebenone on respiratory function in patients with Duchenne muscular dystrophy not using glucocorticoids (DELOS): a double-blind randomised placebo-controlled phase 3 trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

phase III clinical trial

0 references

0 references

Duchenne muscular dystrophy

1 reference

based on heuristic

inferred from title

Maria Grazia D'Angelo

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25907158%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Craig M. McDonald

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25907158%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Christian Rummey

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25907158%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

author name string

Gunnar M Buyse

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25907158%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Thomas Voit

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25907158%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Ulrike Schara

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25907158%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Chiara S M Straathof

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25907158%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Günther Bernert

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25907158%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Jean-Marie Cuisset

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25907158%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Richard S Finkel

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25907158%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Nathalie Goemans

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25907158%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Thomas Meier

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25907158%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

DELOS Study Group

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25907158%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

language of work or name

0 references

publication date

20 April 2015

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25907158%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

385

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25907158%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

9979

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25907158%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

1748-1757

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25907158%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Report of MDA muscle disease symposium on newborn screening for Duchenne muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960025-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Pulmonary function in Duchenne muscular dystrophy related to stage of disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960025-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Respiratory function in the muscular dystrophies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960025-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Lung function in children with Duchenne's muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960025-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality of life, physical disability, and respiratory impairment in Duchenne muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960025-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960025-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960025-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The cooperative international neuromuscular research group Duchenne natural history study: glucocorticoid treatment preserves clinically meaningful functional milestones and reduces rate of disease progression as measured by manual muscle testing an

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960025-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term benefits and adverse effects of intermittent versus daily glucocorticoids in boys with Duchenne muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960025-3

7 January 2021

based on heuristic

inferred from DOI database lookup

NQO1-dependent redox cycling of idebenone: effects on cellular redox potential and energy levels

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960025-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Idebenone and neuroprotection: antioxidant, pro-oxidant, or electron carrier?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960025-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term blinded placebo-controlled study of SNT-MC17/idebenone in the dystrophin deficient mdx mouse: cardiac protection and improved exercise performance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960025-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Idebenone as a novel, therapeutic approach for Duchenne muscular dystrophy: results from a 12 month, double-blind, randomized placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960025-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of glucocorticoids and idebenone on respiratory function in patients with duchenne muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960025-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Spirometry, lung volumes and airway resistance in normal children aged 5 to 18 years

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960025-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Spirometric reference values from a sample of the general U.S. population

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960025-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Maximal static respiratory pressures in children and adolescents.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960025-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Prediction of childhood pulmonary function using ulna length.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960025-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Relationship between peak cough flow and spirometry in Duchenne muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960025-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of pulmonary morbidity for patients with Duchenne muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960025-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Changes in spirometry over time as a prognostic marker in patients with Duchenne muscular dystrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960025-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical implications of maximal respiratory pressure determinations for individuals with Duchenne muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960025-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Peak flow and peak cough flow in the evaluation of expiratory muscle weakness and bulbar impairment in patients with neuromuscular disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960025-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Flow-volume loop changes reflecting respiratory muscle weakness in chronic neuromuscular disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960025-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The use of pulmonary function testing as a quantitative measurement for therapeutic trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960025-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Obstructive apnoeas in Duchenne muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960025-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Inspiratory maneuver effects on peak expiratory flow. Role of lung elastic recoil and expiratory pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960025-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Motor and respiratory heterogeneity in Duchenne patients: Implication for clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960025-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960025-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960025-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety, Tolerability, and Pharmacokinetics of High-Dose Idebenone in Patients With Friedreich Ataxia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960025-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of pulmonary morbidity for patients with neuromuscular disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960025-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The cooperative international neuromuscular research group Duchenne natural history study--a longitudinal investigation in the era of glucocorticoid therapy: design of protocol and the methods used

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960025-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Current treatment and management of dystrophinopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960025-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34669498&oldid=1954595485"